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Insulin resistance and hyperinsulinemia are generally associated with obesity. Obese non-diabetic
individuals develop a compensatory beta-cell response to adjust insulin levels to the increased
demand, maintaining euglycemia. Although several studies indicate that this compensation relies
on structural changes, the existence of beta-cell functional adaptations is incompletely under-
stood. Here, we fed female mice with high-fat-diet (HFD) for 12 weeks. These animals became
obese, hyperinsulinemic, insulin resistant and mild glucose intolerant while fed and fasting gly-
cemia was comparable in HFD and control mice. Islets from HFD animals exhibited increased beta-
cell mass and hypertrophy. Additionally, they had enhanced insulin gene expression and content
and augmented glucose-induced insulin secretion. Electrophysiological examination of beta-cells
from both groups showed no differences in KATP channel open probability and conductance.
However, action potentials elicited by glucose had larger amplitude in obese mice. Glucose-in-
duced Ca2 signals in intact islets, in isolated beta-cells and individual beta-cells within islets were
also increased in HFD mice. Additionally, a higher proportion of glucose-responsive cells was
present in obese mice. In contrast, whole-cell Ca2 current densities were similar in both groups.
Capacitance measurements showed that depolarization-evoked exocytosis was enhanced in HFD
beta-cells compared with controls. Although this augment was not significant when capacitance
increases of the whole beta-cell population were normalized to cell size, the exocytotic output
varied significantlywhenbeta-cellswere distributedby size ranges. All these findings indicate that
beta-cell functional adaptations are present in the islet compensatory response to obesity.
Obesity is an important risk factor for the developmentof type 2 diabetes. Insulin resistance and hyperinsu-
linemia are commonly found in obese individuals, and the
relationship and evolution of both factors is involved in
the eventual progression fromnormal glucose tolerance to
overt diabetes. Although decreased insulin sensitivity is
present in most obese individuals, normal glucose toler-
ance is preserved in these subjects because insulin resis-
tance is compensated by enhanced pancreatic insulin re-
lease, which leads to hyperinsulinemia (1, 2). This
adaptation allows for euglycemia or near normoglycemia
in these situations (3). However, if the reciprocal -cell
compensation fails to match the increased insulin needs,
obese insulin-resistant individuals can progress to im-
pairedglucose toleranceand, eventually, to type2diabetes
(1, 2). Thus, the adaptation of the-cell secretory capacity
is crucial to avoid impaired glucose homeostasis.
In the progression to diabetes, a gradual decline in
-cell mass and/or function leads to inadequate insulin
secretion and increasing plasma glucose levels (2, 4–6).
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-cell dysfunction in obese subjects has been associated to
glucolipotoxicity or islet amyloid polypeptide among
other factors (4, 6–8). In contrast, little is known about
the mechanisms allowing for -cell compensation to obe-
sity, or other insulin-resistance states, and the appearance
of hyperinsulinemia. Treatment of rodents with high-fat-
diet provides a good experimental model to study -cell
adaptation and failure in obesity (8, 9). Diet-induced
obese mice gradually develop insulin resistance, hyperin-
sulinemia and, if compensatory mechanisms fail, may
present hyperglycemia. It has been shown that the adap-
tationprocess involves enhanced insulin release.Although
numerous studies in both animalmodels andhumans have
demonstrated that this augmented secretory response in
insulin resistance states is associated with compensatory
changes in-cellmass, the functional adaptationof-cells
remains controversial (1, 8, 10–12). Therefore, in the
present study we examined the functional contribution of
individual -cells to the whole insulin secretory response
by studying key steps in the stimulus-secretion coupling.
Materials and Methods
Animals, diets and plasma parameters. All protocols were
approvedbyourAnimalEthicsCommittee according tonational
regulations. Experiments were performed with C57BL/6J mice.
After weaning, 21 d-old female pups were fed for 12 wk with
either of the following diets from Research Diets (New Bruns-
wick, NJ, USA): normal diet (ND; 10% fat, 20% protein and
70% carbohydrates; ref.: D12450B) or high fat diet (HFD; 60%
fat, 20% protein and 20% carbohydrates; ref.: D12492). Ani-
mals were housed in groups of 3 individuals at 22°C and light
cycle of 12 h (8.00 am – 8.00 pm). Glucose and insulin plasma
levels as well as intraperitoneal glucose tolerance tests (ipGTT)
and intraperitoneal insulin tolerance tests (ipITT) were per-
formed as previously published (13). About 15% of mice were
resistant to HFD and did not exhibit weight changes compared
with controls. These animals were not considered in this study.
Islet isolation and cell culture.Mice were sacrificed at 15 wk
old by cervical dislocation and islets were then isolated by col-
lagenase digestion (14). In some experiments, isolated isletswere
dispersed into single cells by trypsin enzymatic digestion and
then cultured overnight at 37°C in RPMI 1640 (Sigma, Madrid,
Spain) supplemented with 10% fetal calf serum, 100 IU/ml pen-
icillin, 0.1 mg/ml streptomycin and 11 mM D-glucose (14). Ex-
cept when indicated, all experiments were done at 37°C.
Quantitative real-time PCR. Quantitative PCR assays were
performed using CFX96 Real Time System (Bio-Rad, Hercules,
CA), as previously published (15). Primers for insulin were:
TTATTGTTTCAACATGGCCC (forward); CAAAGGTGCT-
GCTTGACAAA (reverse).
Insulin secretion and content measurement
These parameters were analyzed according to protocols pub-
lished elsewhere (16, 17). Briefly, freshly isolated islets were left
to recover in the isolation medium for 2h in the incubator. After
recovery, groups of 5 islets were transferred to 400l of a buffer
solution containing (in mM): 140 NaCl, 4.5 KCl, 2.5 CaCl2, 1
MgCl2, 20HEPES and the corresponding glucose concentration
with final pH at 7.4. Afterwards, 100 l of the corresponding
buffer solution with 5% BSA was added, incubated at room
temperature for 3 min and let to cool down for 15 min on ice.
Then, the medium was collected and insulin was measured in
duplicate samples by radioimmunoassay (RIA) using a Coat-a-
Count kit (Siemens, Los Angeles, CA, USA). To obtain insulin
content, the islets grouped in batches of 5 were hand-picked and
incubated overnight in an ethanol/HCl buffer at 4°C. At the end
of the incubation period, the buffer was removed and studied for
insulin content. Protein concentration was measured by the
Bradford dye method.
Immunocytochemistry, immunohistochemistry and
-cell mass
Pancreas samples were removed and fixed overnight in 4%
paraformaldehyde. Subsequently, pancreatic tissue was embed-
ded in paraffin and sections were prepared and stained for -cell
identification according to Montanya et al. (18). For quantifi-
cation of -cell area, sections were viewed at a magnification of
20x. The islet cross-sectional area and total pancreatic area was
measured using the analysis program Metamorph Software. At
least 2 sections, separated by 200mweremeasured per animal.
In the case of the immnocytochemistry, insulin-containing cells
were identified with monoclonal anti-insulin mouse antibodies
(1:200; Sigma) as previously described (14).
Ca2 signaling measurements by fluorescence microscopy and
confocal microscopy.Isolated islets and single cells were loaded
with either Fura-2 or Fluo-4 (2 M for cells and 5 M for islets)
for 1 h at room temperature (14). Ca2 signals were recorded
using an inverted epifluorescencemicroscope equippedwith 340
and380nmband-pass filters (14, 16). Fluorescence recordswere
expressed as the ratio of fluorescence at 340 nm and 380 nm
(F340/F380) and the increment of fluorescence (F) was ob-
tained by subtracting the mean basal fluorescence in the absence
of stimulus from the fluorescence value during the stimulus. As
previously described (17, 19), when the stimuli induced a single
Ca2 transient, such as K or the initial response to glucose, we
analyzed the maximal amplitude of this transient (F) as an
indicator of the Ca2 signal magnitude. Since glucose also in-
duces Ca2 oscillations, we analyzed the area-underthe-curve
(AUC) of the whole period of stimulation using Origin software
(Origin, Origin Lab Corporation, MA USA). This parameter is
an indicator of the global Ca2 increase (19). For the analysis of
synchrony as well as the first Ca2 transient with glucose, indi-
vidual cellswithin intact isletsweremonitoredusing aZeiss LSM
510 laser confocalmicroscope (optical section8m) (14). The
Ca2 signal of 4–7 individual -cells were analyzed in each islet.
A synchronized cell within an islet was considered when the
analyzed cell exhibited coupling of its Ca2 oscillations with the
rest of cells (20, 21). -cells were identified by their typical Ca2
response to glucose (20, 21).
Patch-clamp recordings. Electrophysiological measurements
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were carried out using an EPC-10 USB patch-clamp amplifier in
conjunction with the Patch Master Software suite (HEKA Elek-
tronic) or, in the case of KATP channel experiments, using an
Axopatch 200B patch-clamp amplifier in conjunction with the
pClamp Software (Axon InstrumentsCo). Electrodesweremade
from borosilicate glasses using a P-97 flaming/brown micropi-
pette puller (Sutter Instrument Co) coated with Sylgard 184
(Dow Corning) and polished with a MF-830 microforge (Na-
rishige) and had resistances between 4–6 when filled with the
different pipette solutions. Voltage-gated Ca2 currents were
measured using the standard whole-cell configuration with a
pipette solution containing (in mM): 130 CsCl, 1 MgCl2, 1
CaCl2, 10 EGTA, 3 Mg-ATP and 10 HEPES (pH 7.2 with
CsOH). During Ca2 channel measurements, cells were bathed
in a medium containing (in mM): 118 NaCl, 10 TEA-Cl, 4.8
CsCl, 1.2 MgCl2, 5 CaCl2 5 HEPES and 5 D-glucose (pH 7.4
with NaOH). The perforated-patch configuration was used for
the membrane potential recordings. The pipette solution con-
tained (inmM): 76K2SO4, 10NaCl, 10KCl, 1MgCl2, 5HEPES
(pH 7.35 with KOH) and 0.24 mg/ml of the pore forming anti-
bioticAmphotericin B; the bath solution contained (inmM): 140
NaCl, 3.6 KCl, 1.5 CaCl2, 5 NaHCO3, 0.5 MgSO4, 0.5
NaH2PO4, 10 HEPES (pH 7.4 with NaOH) and D-glucose as
indicated. KATP channel activity was recorded using standard
patch-clamp recording procedures with a pipette solution con-
taining (inmM): 140KCl, 1MgCl2, 10HEPES and 1 EGTA (pH
7.2). In these experiments, the bath solution contained (in mM):
5 KCl, 135NaCl, 2.5 CaCl2, 10HEPES and 1.1MgCl2 (pH 7.4)
and supplemented with D-glucose as indicated. KATP channel
activity was quantified as previously described (21). Exocytosis
was monitored using the standard whole-cell configuration and
recording cell capacitance changes through the sineDC mode
of the Lock-In amplifier included in the Patch Master software.
For these experiments the pipette solution contained (in mM):
140CsCl, 10NaCl, 1MgCl2, 0.05EGTA, 3Mg-ATP, 0.1 cAMP
and 5 HEPES (pH 7.2 with CsOH), while bath solution con-
tained (in mM): 118 NaCl, 5.6 KCl, 20 TEA-Cl, 1.2 MgCl2, 5
CaCl2, 5 HEPES and 5 D-glucose (pH 7.4 with NaOH). Only
experiments with stable and low access resistance and small leak
currents were used. The seal resistance value was typically 
3M. No differences were allowed between ND and HFD
groups in any of these parameters. KATP channel experiments
were carried out at room temperature (20–24°C). All the other
experiments were carried out at physiological temperature (34–
36°C). -cells were identified by their electrical response to glu-
cose and steady state inactivation of Na currents (22; Supple-
mental Figure 1).
Statistical analysis. Data is shown as mean  SE. Student’s t
test or one-way ANOVA with Bonferroni correction were per-
formed with a level of significance P  .05.
Results
Obese mice exhibit increased body weight and
hyperinsulinemia. Female mice were fed with either high
fat (HFD) or normal diet (ND) for 12 wk. At the end of
both treatments, HFD mice displayed increased body
weight and fed hyperinsulinemia compared to controls
(Figure1A-B),while glycemia in fed state remained similar
(Figure 1C). When mice were subjected to ipGTT, initial
fasting plasma glucose levels showed a very mild increase
in obese mice (ND  95.4  4.4 mg/dl; HFD  105.9 
3.4 mg/dl) (Figure 1D). Obese mice presented glucose in-
tolerance at 15 and 30min, yet glucose values were found
similar after 2 h of the glucose load (Figure 1D). Addi-
tionally, analysis of ipITT revealed decreased insulin sen-
sitivity forHFDmice (Figure 1E). To further check for this
insulin resistance, plasma glucose and insulin levels were
measured before an intraperitoneal glucose load and after
30min (Figure 1F andG). These experiments showed that
HFD mice were hyperinsulinemic at 0 and 30 min com-
pared with controls, while glucose levels remained similar
in both groups. All these results are compatible with a
model ofHFD-induced obesitywith insulin resistance and
moderate glucose intolerance, in which plasma glucose
levels remained near normoglycemia at the expense of in-
creased plasma insulin levels.
High-fat diet leads to increased -cell mass and -cell
hypertrophy.Hyperinsulinemia has been frequently asso-
Figure 1. Metabolic features in HFD and control mice. A:
Body weight (n  10 and 13 mice for ND and HFD, respectively). Fed
plasma insulin (B; n  8 mice for each group) and glucose (C; n  9
and 12 mice for ND and HFD, respectively) in mice submitted to
normal and high fat diet. Glucose tolerance test (D; n  11 and 12
mice for ND and HFD, respectively) and insulin tolerance test (E; n  6
mice for each group). Obese and lean mice were subjected to an
intraperitoneal glucose load and then, plasma glucose (F) and insulin
levels (G) were measured at 0 and 30 min (n  6 and 8 mice for ND
and HFD, respectively). ND: Normal diet; HFD: high fat diet. Statistically
significant: *; P  .05; **, P  .01; ***, P  .001; ns, non significant.
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ciatedwith enhanced -cell mass in obesity models (2). As
shown in Figure 2A-C, the pancreas size and relative and
absolute -cell mass were found bigger in obese mice.
Since the involvement of-cell size is still controversial (7,
8, 10), we evaluated this parameter by different approach-
es: average area occupied per single -cell in islets from
pancreas sections (Figure 2D), cell size estimated from sin-
gle -cell membrane capacitance compensation during
electrophysiological recordings (Figure 2E) and -cell di-
ameter analysis in immuno-identified isolated-cells (Fig-
ure 2F,G). -cell size measurements were similar to those
previously reported (23, 24). All these experiments indi-
cated that -cell hypertrophy was present during diet-in-
duced obesity.
Pancreatic islets from obese mice show enhanced insulin
release in response to glucose. Insulin gene expression as
well as insulin protein content were increased in pancre-
atic islets fromobesemice comparedwith controls (Figure
3A,B). When the islet secretory capacity was analyzed in
vitro, we also observed enhanced insulin release in re-
sponse to glucose in obesemice (Figure 3C-D). Thus, these
findings indicate that hyperinsulinemia in obesemicemay
be associated to the enhanced secretory capacity of their
islets. Since there is notmuch information about themech-
anisms involved in this hypersecretion, the next experi-
ments were designed to analyze the main signaling events
involved in -cell insulin release.
Action potentials during glucose stimulation have higher
amplitude in-cells fromHFDmice.KATPchannelsplaya
central role in coupling metabolic changes to -cell excit-
ability and insulin secretion. Cell-attached measurements
revealed thatKATP channel openprobability in response to
glucose was similar in -cells from both groups (Figure
4A,B). This finding was further supported when the KATP
channel slope conductance was analyzed through the ap-
plicationof voltage ramps in theperforated-patchvoltage-
clamp configuration (Figure 4C). In this case, slope con-
ductance values normalized to cell capacitance in response
to 3 and 8mMglucose aswell as tolbutamidewere similar
between both groups (Figure 4D). Thus, glucose-induced
changes in KATP channel activity are unlikely to play a
major role in the insulin secretion differences observed in
obese mice. Consistent with this, the characteristic glu-
cose-induced hyperpolarization of the mitochondrial
membrane potential (m) was found similar in both
groups (Supplemental Figure 2), suggesting a comparable
mitochondrial activation in HFD and control islets in re-
sponse to glucose.
Perforated-patch recordings allowed us to study
plasma membrane potential changes in response to glu-
cose without disturbing the intracellular milieu. These ex-
periments showed that resting membrane potential at 3
mM glucose was virtually identical among both groups
(ND –78  0.7 mV; HFD –78  1.0 mV) (Figure
4E,F). Upon stimulation with 8 mM glucose, -cells from
obese and lean mice depolarized to similar values (ND
–43  1.0 mV; HFD –45  1.0
mV). These membrane potential lev-
els are characterized by the appear-
ance of action potentials in both
groups (Figure 4E,G). Interestingly,
while no significant differences ex-
isted in the firing frequency (Figure
4H) or the action potential duration
(data not shown), the peak ampli-
tude of action potentials was largely
enhanced by 	35% in -cells from
HFD mice compared with controls
(Figure 4I,J), leading to peak volt-
ages of 3.7 2.0mV and –6.9 2.0
mV, respectively.
Figure 2. Structural changes in obese mice compared with controls. Pancreas
weight (A), relative (B) and absolute (C) -cell mass as well as -cell cross-sectional area (D) was
quantified in both groups by immunohistochemistry in pancreas sections. At least 300 islets from
5–7 different pancreases were analyzed in each condition. -cell mean size in HFD and ND mice
was also evaluated by electrophysiology from capacitance measurements (E) and by image
analysis from immunoidentified -cells isolated in culture (F). In the former case, cell size was
expressed in pF (23). G: Normalized size distribution frequency of experiments shown in F. The
numbers in parenthesis indicate the number of analyzed cells. ND: Normal diet; HFD: high fat
diet; pF: picofarads. Statistically significant: **, P  .01 comparing ND and HFD; ***, P  .001.
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-cells from obese mice have enhanced Ca2 signals
in response to glucose.To study Ca2 dynamics in in-
tact islets from both models, we measured intracel-
lular Ca2 signals by Fura-2 and fluorescence micros-
copy.As shown in Figure5A, exposureof islets toboth
8 and 16 mM glucose produced a transient Ca2 rise
followed by oscillations in both groups. However, in
the case of HFD islets, the Ca2 response resulted in a
higher amplitude of the transient rise as well as in-
creased area-underthe-curve (AUC) of the whole sig-
nal (Figure 5B,C). Unlike glucose, a nonmetabolic
stimulus suchasKdidnot lead todifferent responses
(Figure 5D,E). Glucose induced similar effects in iso-
lated -cells in culture (Figure 5F and Supplemental
Figure 3). In these experiments,we also observed that
the percentage of cells responding to glucose was in-
creased in obese mice (Figure 5G). Finally, to further
check whether enhanced islet Ca2 responses were
due to improved Ca2 signals in individual -cells, we
studied single cells by confocal microscopy in thin op-
tical slices (8 m) within intact islets. As shown in
figure 5H,I, glucose-inducedCa2 signals in individual
-cells were also enlarged in HFD mice. Unlike ampli-
tude andAUC, theoscillatory frequencywas similar in
both groups at 11mMglucose (1.53 0.8 oscillations/
minand1.540.8oscillations/min inNDandHFD;n
19 and 54 cells, respectively). Since insulin secretion
also relies on the efficiency of cell-to-cell coupling
(20), we analyzed the synchrony of oscillatory Ca2
signals among cells. However, no major differences
were foundbetweenboth groups (Supplemental Fig-
ure 4). In order to study modifications in the voltage-
dependent Ca2 currents, we then performed stan-
dard whole-cell patch-clamp measurements in
isolated -cells from both groups. The peak Ca2 cur-
rents as well as the Ca2 charge transfer were found
larger in -cells from obese mice (Figure 5J and Sup-
plemental Figure 5). However, these differences dis-
appearedwhentheseparameterswerenormalized to
cell capacitance (Figure 5K). It has been reported that
fatty acids increases L-type Ca2 channels (25, 26). In
both models, the contribution of these channels to
the Ca2 currents was comparable, since the blocker
nifedipine led to similar inhibition (Supplemental Fig-
ure 6).
Exocytotic responses in -cells from HFD mice and
controls. Simultaneous measurements of depolarization-
evoked capacitance changes and Ca2 currents were used
to study diet effects on exocytosis (27). -cells were sub-
jected to a train of ten 500ms voltage depolarizations from
–70 to 0 mV (Figure 6A,B). This protocol leads to further
expansion of the Ca2microdomains associated with the
Figure 3. Insulin secretion, content and gene expression in
obese and lean mice. Insulin gene expression from isolated islets
from HFD and ND mice was analyzed by real-time PCR (A; n  13 and
8 samples, respectively) while insulin content by RIA (B; n  12
samples per condition). Insulin content was normalized to total protein
content. C, D: Insulin release in response to 3, 8 and 16 mM glucose
was measured by RIA in isolated islets from both groups. Insulin
secretion was expressed as the percentage of insulin content (C) or
normalized to total protein content (D) (n n  12 samples per
condition). ND: Normal diet; HFD: high fat diet. Statistically significant:
*; P  .05.
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release of the ready releasable pool (RRP) and triggers the
recruitment of deeper granules (28). These experiments
led to enhanced exocytotic responses in HFD in regard to
the early (first two pulses) as well as late (pulses from 3 to
10) components of the exocytosis (Figure 6C). Due to the
increased -cell size in HFD, these differences were not
significant when normalized to this parameter (Figure
6D). We also performed experiments with 50 ms pulses
(Figure 6E,F). This action potential-like stimulation is
tightly related to the release of granules that are attached
to Ca2 channels (28). Similar results were obtained as
those observed for 500 ms (Figure 6E,F). In both types of
stimulation, integrated Ca2-currents normalized to cell
size elicited during each pulse as well as the exocytosis
Ca2 efficiency were not significantly different between
both groups (Supplemental Figure 7). The capacitance
voltage-dependence was also similar in both groups, al-
though some values between -10mV and 10mV tended to
be higher in HFD (Figure 6G,H).Whenwe considered the
whole population, which showed an ample cell size dis-
persion (Figure 6I,J), no significant differences between
both groups were found in the normalized capacitance
increase (Figure 6D,F), suggesting that the enhanced ca-
pacitance responses inHFD-cells were likely due to their
increased cell size. However, interestingly, whenmaximal
capacitance increases in response to 500ms pulses were
plotted against cell size (Figure 6I-K), this correlation was
not obvious, showing that bigger cells tended to secrete
with less efficiency. Actually, when cells were separated in
size ranges (Figure 6K), we found that the exocytotic re-
sponse of -cells within 5 and 6.5 pF was higher in obese
mice compared with both control cells of the same range
and the bigger HFD cells. This effect
was more pronounced in the reserve
pool (Figure 6K). These results indi-
cate that HFD -cell exocytosis be-
havior might be heterogeneous de-
pending on cell size.
Discussion
During prediabetic stages in obesity,
compensatory-cell changes oppose
to insulin resistance, allowing for
normoglycemia. However, when
this adaptation fails, progression to
hyperglycemia and frank diabetes
may eventually occur (2, 4–6). The
mechanisms involved in -cell dys-
function and diabetes development
have received much attention. Yet,
less is known about the processes
participating in -cell compensatory
changes in prediabetic stages. In
both animals and humans, the in-
crease in -cell mass is critical in this
adaptative response in obesity
(5,10–12,29). However, the exact
contribution of -cell functional
changes is still unclear (1, 2, 11, 12).
In the present study, we showed that
femalemice subjected toHFD for 12
wk exhibit moderate glucose intol-
erance and insulin resistance as well
as hyperinsulinemia. Given that fed
and fasting plasma glucose levels in
HFD mice were not much different
Figure 4. Glucose-stimulated KATP channel activity and membrane potential in
-cells from HFD and control mice. A: Representative example of KATP channel activity in
response to 0, 8 and 16 mM glucose as well as 100 M diazoxide in an isolated HFD -cell.
Channel activity was measured by patch-clamp in cell-attached configuration. B: KATP channel
open probability obtained from 8 cells of control mice and 9 cells of HFD mice. C: The membrane
potential was ramped from –100 to 0 mV to estimate the slope conductance of -cells in
different conditions. The graph illustrates the current-voltage relationship in a control -cell
during these voltage ramps. D: Slope conductance normalized to membrane capacitance was
obtained from the linear part (between –100 and –50 mV) of the current-voltage relationship
shown in C in isolated -cells from both groups (n  15 isolated cells for each group). E:
Representative examples of membrane potential variations in response to 8 mM glucose in both
groups of mice. These recordings were obtained by perforated-patch current-clamp. Letters (a-d)
indicate the times when the voltage ramp protocols shown in C and D were obtained. F:
Membrane potential at 3 and 8 mM glucose is shown for both groups. Several parameters
related with the action potentials were also compared in both groups: baseline membrane
potential from which arose action potentials (G), firing frequency (H) and peak amplitude (I) (n 
16 and 13 isolated cells for ND and HFD, respectively). J: Two representative -cell action
potentials from ND and HFD mice, respectively, are illustrated for comparison. G: glucose; Diaz:
diazoxide; Tlb: tolbutamide; ND: Normal diet; HFD: high fat diet. Statistically significant
comparing ND and HFD: *; P  .05. Statistically significant comparing with ND control: &, P 
.05. Statistically significant comparing with HFD control: $, P  .05. NS: nonsignificant.
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to those of lean controls, it indicates that plasma glucose
concentrations were maintained near normoglycemia at
the expense of an increased insulin output, suggesting an
adaptative compensatory response. Consistent with this,
we observed increased plasma insulin levels before and
after a glucose load in HFD mice compared with lean
controls (Figure 1). It has been shown thatHFD protocols
can lead to different metabolic outcomes in male mice
compared to those described here in females, leading to
-cell dysfunction and overt hyperglycemia (4, 6). How-
ever, it has been previously reported that female mice are
protected againstHFD, insulin resistance and progression
to diabetes (30, 31). Actually, we chose female mice be-
cause it has been suggested to provide a better model to
study the initial prediabetic stages of the compensatory
response (9, 32). This is likely related with the protective
effect of estrogens (30, 31). It has been shown that chronic
estradiol administration inwild-type ovariectomizedmice
exerts a beneficial effect against HFD induced glucose in-
tolerance, while these actions do not occur in estrogen
receptor alpha knockout mice (30). Similar protective ef-
fects have been reported in animal models of insulin de-
ficient diabetes (31). Additionally, compared with other
strains, C57BL/6J mice are more resistant to diet-induced
obesity, which allows a better characterization of predi-
abetic conditions.Differences in the protocols used for the
dietary treatment may also lead to variances in -cell phe-
notypes in males and females during obesity. Given that
the exposure to HFD started at 3 wk old, we cannot dis-
card that, in addition to functional changes, the diet also
affected -cell growth processes.
Increased -cell mass is a hall-
mark of the islet adaptative response
to obesity and it has been mainly as-
sociated to hyperplasia (7, 8, 10). In
agreement with this, we observed
that-cellmasswas enlarged inHFD
mice (Figure 2). Interestingly, while
others have not found changes in
-cell size in HFD models (7), we
showed here that obese mice exhib-
ited -cell hypertrophy, indicating
that this is also a key process in the
-cell structural adaptations to obe-
sity. Additionally, we show that iso-
lated islets from obese mice dis-
played higher insulin gene
expression and protein content as
well as enhanced secretory output in
response to glucose compared with
controls (Figure 3). Few studies in di-
et-induced obese mice or insulin-re-
sistant states have suggested that
changes in islet metabolism may ac-
count for the augmented insulin se-
cretion (8, 9, 32, 33). However, if a
metabolic change was present in our
experiments, it did not affect the
KATP channel activity, the KATP
channel slope conductance or the
plasma membrane potential in re-
sponse to glucose. Actually, most
differences observed in this study
were found down-stream of KATP
channels. In any case, several glu-
cose-derived metabolic factors dif-
ferent from ATP such as NADH and
Figure 5. Glucose-induced Ca2 signaling in -cells of obese and control mice. A:
Intracellular Ca2 signals were measured in intact islets by conventional fluorescence microscopy
and Fura-2. Two examples of the Ca2 signal are illustrated for both groups in response to 8 and
16 mM glucose. B: Analysis of the fluorescence increase (F) during the first Ca2 transient in
response to 8 and 16 mM glucose. C: Analysis of the area under the curve (AUC) of the whole
stimulation period as a global indicator of the Ca2 signal during the stimulus. D: Two examples
of the Ca2 signal are illustrated for both groups in response to depolarization induced by 75
mM KCl. E: Analysis of the fluorescence increase (F) during the Ca2 transient in response to
KCl. F: Area under the curve (AUC) of the whole stimulation period in response to glucose in
isolated islet cells in culture. G: Percentage of responsive cells to glucose in isolated -cells of
obese mice and controls (n  54 and 43 isolated -cells for ND and HFD, respectively). H: Ca2
signals in individual -cells were measured in thin optical sections (8 m) of intact islets by
confocal microscopy and Fluo-4. The images show the fluorescence increase in response to
glucose during a Ca2 signal in individual cells from a control mice (left) or obese (right). I:
Fluorescence increase (F) during the first Ca2 transient in response to 11 mM glucose in
individual cells within islets from experiments shown in H. J: Ca2 currents in -cells from both
groups in response to a depolarizing pulse from –70 mV. K: Ca2 current densities versus
voltages in -cells of obese and lean mice. The numbers in parenthesis indicate the number of
analyzed cells. G: glucose; ND: Normal diet; HFD: high fat diet; F: fluorescence; Fb: basal
fluorescence. Statistically significant: *; P  .05; **, P  .01; ***, P  .001.
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glutamate have been involved as intracellularmediators of
glucose-induced insulin secretion (34, 35). In addition to
diet-induced obese mice, an increased secretory perfor-
mance has been also reported in obese Zucker fatty rats
(1). In contrast, other studies have shown that -cell com-
pensation relies mainly on structural adaptations rather
than changes in the secretory efficiency (10, 12). In part,
these discrepancies might be probably due to the different
metabolic outputs that are obtained depending on the
mice gender, diet fat content as well as duration and life
periods of the dietary treatment (36).
In addition to structural changes, the present study
shows that the compensatory response during prediabetic
early stages in obesity is also sustained by-cell functional
changes at different levels, probably down-streamofKATP
channels, as commented earlier. Interestingly,-cells from
obesemice exhibited action potentials of larger amplitude
(Figure 4I,J). If we take into account the difference in the
plasma membrane potential voltages achieved by both
groups and the voltage-dependence of Ca2 currents (Fig-
ure 5K) and exocytosis (Figure 6H), we should expect that
action potentials fired by HFD -cells lead to increased
Ca2-currents and exocytosis. This may explain the en-
hancedCa2 signals andglucose-induced insulin release in
HFD -cells (Figure 3 and 5). It is noteworthy to mention
that recent work has shown that pharmacological inhibi-
tion of BK channels leads to taller action potentials, which
increases Ca2 currents, Ca2 signals and insulin release
(37–39). Consistent with this, the use of a BK channel
blocker leads to enhanced Ca2 responses in islets from
normal mice (P. Ñeco, B.Merino, A. Gonzalez, A. Nadal,
I. Quesada, unpublished preliminary results). Thus, al-
though this possibility would require further investiga-
tion, it is tempting to speculate that modifications at the
level of these channels might be in-
volved in the larger action potentials
observed in HFD -cells.
Analysis of glucose-inducedCa2
signals in intact islets, in individual
-cells within islets and isolated cells
in culture revealed enhanced Ca2
responses in obese mice. Addition-
ally, higher cell recruitment in re-
sponse to glucose was observed in
HFD. The voltage-dependence of
-cell exocytosis correlates very well
to that of the inward Ca2 currents
and the magnitude of the Ca2 sig-
nals (40). Thus, it is expected that a
higher Ca2 entry trough voltage-
dependent Ca2-channels would
lead to enhanced Ca2 signals as a
trigger for exocytosis, resulting in
more secretion. When Ca2 current
densities were evaluated in condi-
tions where cell metabolism is not
preserved, nomajor differenceswere
found between HFD and controls.
Similarly, a nonmetabolic stimulus
such as KCl did not produce Ca2
signal differences. Thus, it is likely
that a metabolism product may be
involved with the glucose-induced
changes in HFDmice. In this regard,
it has been reported that glucose-de-
rivedmolecules such asATP,NADH
or glutamate are involved in glucose-
induced insulin secretion by modu-
lation of voltage-gated K (Kv) or
Figure 6. Exocytotic responses in -cells from obese and lean mice. A: Examples of
exocytotic responses to ten 500 ms depolarizing pulses (from –70 to 0 mv) in HFD and control
-cells. B: Representative Ca2 currents elicited during the first depolarizing pulse in experiments
shown in A. C: Average capacitance increase for the ready releasable pool (RRP; first two pulses;
(23)), the reserve pool (RP) and for all the depolarizing pulses (total). D: As in C but normalized to
cell size. E: Average capacitance increase after stimulation with fifteen 50 ms depolarizing pulses.
F: As in E but normalized to cell size. G: Representative exocytotic responses to 500 ms
depolarizing pulses from –70 mV to –40, 0, 10 and 20 mV. H: Voltage-dependence of
normalized capacitance increase in HFD and control -cells. I: Maximal capacitance increases in
response to ten 500 ms depolarizing pulses versus cell size (n  25 and 33 isolated cells for ND
and HFD, respectively). J: As in I but normalized to cell size. K: Normalized capacitance increase
from experiments in J, but separated in cell size ranges (size ranges which prevented differences
in this parameter between groups): 5–6.5 pF (n  19 and 16 cells for control and HFD mice,
respectively) and  6.5 pF (n  3 and 17 cells for control and HFD mice, respectively). Numbers
in parenthesis indicate the number of analyzed cells. ND: Normal diet; HFD: high fat diet.
Statistically significant: *, a, b, P  .05; ns: nonsignificant.
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Ca2 channels or the exocytotic machinery (35, 41–45).
The exocytotic response of each individual -cell from
HFD was enhanced respect to controls (Figure 6). These
differences disappeared when capacitance increases were
normalized to cell size, suggesting that the exocytotic ef-
ficiencywas comparable in both groupswhile the absolute
secretory response may be related with the hypertrophy
found inHFD -cells (Figure 2). However, in the case that
similar exocytotic efficiency would be present in both
models, the taller action potentials and increased Ca2
signals as well as the bigger cell size in HFD -cells would
lead to enhanced secretion. Actually, increased insulin
output was observed in HFD islets compared to controls
(Figure 3). Intriguingly, a clear correspondence between
maximal capacitance increase and cell size was not found.
In fact, medium-size HFD -cells seemed to be more vig-
orous in terms of secretion compared with both bigger
HFDcells and controlmedium-size cells. This observation
also points to an enhanced secretion in obese mice. Het-
erogeneous secretion depending on cell size has been pre-
viously observed in -cells (24). This could be an inter-
esting aspect since itmay suggest that increased exocytosis
in medium-size -cells may result from an adaptative re-
sponse to obesity. In contrast, given that hypertrophy has
been associated to -cell dedifferentiation and senescence
(46–48), bigger -cells might be less efficient or lose the
adaptative response. In this regard, it would be interesting
to study how this heterogeneity in cell size and exocytosis
evolves during obesity and its relationship with the onset
of diabetes.
In summary, in the present study we show that, in ad-
dition to the well-known compensatory changes in -cell
mass during prediabetic stages in obesity, -cells develop
hypertrophy and, independently, several functional adap-
tations, all of which may allow, individually or coopera-
tively, for the enhanced glucose-induced insulin-release
shown here. These functional changes consist of higher
actionpotentials, augmentedCa2 signals and cell recruit-
ment as well as more efficient exocytosis in middle-size
-cells.Whether these compensatoryadaptations couldbe
manipulated, it would be of interest for the design of ther-
apeutic strategies against hyperglycemia and diabetes.
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